ADITX Therapeutics
$2.739876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.73
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.01 (+0.37%) Today
$0.00 (0.00%) As of 11:28 PM UTC after-hours
Why Robinhood?
You can buy or sell ADTX and other stocks, options, and ETFs commission-free!
About ADTX
ADiTx Therapeutics, Inc. engages in the development of biotechnologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. It has a worldwide license for commercializing a nucleic acid-based technology, named Apoptotic DNA Immunotherapy (ADi), which utilizes a novel approach that mimics the way the body naturally induces tolerance to its own tissue.
CEO
Amro Albanna
Employees
43
Headquarters
Mountain View, California
Founded
2017
Market Cap
36.33M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
288.51K
High Today
$2.80
Low Today
$2.63
Open Price
$2.66
Volume
209.15K
52 Week High
$9.58
52 Week Low
$1.62
ADTX Earnings
-$0.37
-$0.25
-$0.12
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours